VERIFIED Q&AS AND DETAILED RATIONALES
NURSE PRACTITIONER CERTIFICATION PREP
GUIDE (FNP & AGNP)
This comprehensive study package delivers 200 verified,
high-yield practice questions complete with immediate
answers and detailed clinical rationales designed to mirror
the actual exam environment. It targets critical primary care
domains, high-volume clinical systems, and core
pharmacology guidelines across the lifespan to maximize
your testing performance. Perfect for fast-paced review, this
guide directly sharpens diagnostic skills and highlights
common test traps to ensure a passing score on your
national boards.
Question 1
A 45-year-old male presents with a sudden onset of severe pain,
erythema, and swelling in his left great toe. He notes the pain
started last night after a steak and beer dinner. Lab results reveal
an elevated serum uric acid level. Which of the following is the
most appropriate first-line treatment for an acute flare of this
condition?
A) Allopurinol (Zyloprim)
B) Colchicine (Colcrys)
,C) Indomethacin (Indocin)
D) Febuxostat (Uloric)
Answer: C
Rationale: First-line treatment for an acute gout flare
includes oral Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
such as indomethacin, naproxen, or sulindac, or systemic
corticosteroids if NSAIDs are contraindicated. Colchicine is
an alternative if initiated within 36 hours of onset. Xanthine
oxidase inhibitors like allopurinol and febuxostat are used
for chronic maintenance therapy to lower uric acid levels but
should never be initiated or altered during an acute attack, as
rapid fluctuations in uric acid can worsen or prolong the
acute flare.
Question 2
A 68-year-old female presents for a routine wellness exam. Her
screening bone densitometry (DXA) scan reveals a T-score of -
2.8 at the femoral neck. She has no history of fractures. Which of
the following is the most appropriate initial pharmacological
choice for this patient?
A) Alendronate (Fosamax)
B) Raloxifene (Evista)
C) Teriparatide (Forteo)
D) Denosumab (Prolia)
Answer: A
Rationale: A T-score of -2.5 or lower on a DXA scan confirms
a diagnosis of osteoporosis. Oral bisphosphonates, such as
alendronate or risedronate, are considered first-line
pharmacological choices for the prevention and treatment of
osteoporosis due to their proven efficacy in reducing both
,vertebral and hip fractures, low cost, and long-term safety
data. Raloxifene is an option for women with an increased
risk of breast cancer but is less effective at preventing non-
vertebral fractures. Teriparatide and denosumab are typically
reserved for patients with very high fracture risk or those
who fail initial bisphosphonate therapy.
Question 3
An 18-year-old female presents to the clinic requesting
contraception. During her history, she mentions that she
frequently forgets to take her daily multivitamin. She is looking for
a highly effective, long-term method that does not require daily
compliance. Which of the following options should the nurse
practitioner recommend as the most effective?
A) Oral contraceptive pills
B) Etonogestrel subdermal implant (Nexplanon)
C) Medroxyprogesterone acetate injection (Depo-Provera)
D) Male condoms
Answer: B
Rationale: Long-Acting Reversible Contraception (LARC)
methods, including subdermal implants (Nexplanon) and
Intrauterine Devices (IUDs), have the highest tier of efficacy
(>99%) because they completely eliminate user compliance
errors. Oral contraceptive pills and injections require
adherence (daily or every 12 weeks) and carry higher typical-
use failure rates, making them less ideal for a patient who
admits to poor daily compliance. Condoms provide barrier
protection but have a typical-use failure rate of roughly 13%.
Question 4
, A 24-year-old female student presents with a 3-day history of
productive cough, fever of 101.2°F, and right-sided pleuritic chest
pain. Chest X-ray reveals a dense right lower lobe infiltrate. She
has no significant past medical history, no comorbidities, and has
not taken any antibiotics in the past 90 days. According to current
guidelines, what is the preferred first-line empiric treatment for this
patient’s community-acquired pneumonia (CAP)?
A) Levofloxacin (Levaquin) 750 mg PO daily
C) Amoxicillin 1g PO TID plus Azithromycin 500 mg PO on day 1,
then 250 mg daily
C) Ceftriaxone 1g IM once
D) Amoxicillin 1g PO TID or Doxycycline 100 mg PO BID
Answer: D
Rationale: For a healthy adult under 65 with no comorbidities
and no recent antibiotic exposure, first-line empiric treatment
for community-acquired pneumonia (CAP) consists of
monotherapy with Amoxicillin (1g TID) or Doxycycline
(100mg BID), or a macrolide (if local pneumococcal
resistance rates are <25%). Respiratory fluoroquinolones
(like levofloxacin) and combination therapy (beta-lactam plus
macrolide/doxycycline) are reserved for patients with
significant comorbidities (e.g., COPD, diabetes, chronic heart
disease) or recent antibiotic use.
Question 5
A 55-year-old male with a history of type 2 diabetes mellitus
presents for evaluation of his blood pressure. His office readings
over the last two visits have averaged 142/88 mmHg. Today, his
blood pressure is 144/90 mmHg. Urinalysis reveals
microalbuminuria. Which of the following antihypertensive agents